chr4-81142936-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate
The NM_006259.3(PRKG2):c.1265C>T(p.Ser422Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000211 in 1,609,866 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_006259.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PRKG2 | NM_006259.3 | c.1265C>T | p.Ser422Phe | missense_variant | 11/19 | ENST00000264399.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PRKG2 | ENST00000264399.6 | c.1265C>T | p.Ser422Phe | missense_variant | 11/19 | 5 | NM_006259.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152036Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000280 AC: 7AN: 250156Hom.: 0 AF XY: 0.0000370 AC XY: 5AN XY: 135290
GnomAD4 exome AF: 0.0000213 AC: 31AN: 1457830Hom.: 0 Cov.: 31 AF XY: 0.0000234 AC XY: 17AN XY: 725116
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152036Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74270
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 15, 2022 | The c.1265C>T (p.S422F) alteration is located in exon 10 (coding exon 10) of the PRKG2 gene. This alteration results from a C to T substitution at nucleotide position 1265, causing the serine (S) at amino acid position 422 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at